Company: BIAF
Filing Date: 2025-04-15
Form Type: PRE 14A
Source: 0001641172-25-004857
Chunk: 34

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: PRE 14A
Chunk 34
---
 the current authorized number
of shares of Common Stock at various exchange ratios, based on 18,255,824 shares of Common Stock actually issued and outstanding as of
April 8, 2025. The table does not account for fractional shares that will be paid in cash.

|                                                                                                                                                                                                                                  |     | Estimated      
 Number of      
 Shares of      
 Common Stock   
 Before Reverse 
 Stock Split    |             |     | Estimated        
 Number of        
 Shares of        
 Common Stock     
 After Reverse    
 Stock Split on a 
 1-for-10 basis   |             |     | Estimated        
 Number of        
 Shares of        
 Common Stock     
 After Reverse    
 Stock Split on a 
 1-for-25 basis   |             |
| Authorized Common Stock                                                                                                                                                                                                          |     |                | 100,000,000 |     |                  | 100,000,000 |     |                  | 100,000,000 |
| Shares of Common Stock issued and outstanding                                                                                                                                                                                    |     |                |  18,255,824 |     |                  |   1,825,582 |     |                  |     730,232 |
| Shares of Common Stock issuable under outstanding options, warrants or reserved for issuance under existing plans                                                                                                                |     |                |  14,417,258 |     |                  |   1,441,725 |     |                  |     576,690 |
| Shares of Common Stock authorized but unissued (Authorized Common Stock minus issued and outstanding shares, shares issuable upon outstanding options, warrants and shares reserved for issuance under existing incentive plans) |     |                |  67,326,918 |     |                  |  96,732,693 |     |                  |  98,693,078 |

We are currently authorized to issue a maximum of
100,000,000 shares of our Common Stock. As of the Record Date, there were 18,255,824 shares of our Common Stock issued and outstanding.
Although the number of authorized shares of our Common Stock will not change as a result of the Reverse Stock Split, the number of shares
of our Common Stock issued and outstanding will be reduced in proportion to the ratio selected by the Board. Thus, the Reverse Stock Split
will effectively increase the number of authorized and unissued shares of our Common Stock available for future issuance by the amount
of the reduction effected by the Reverse Stock Split.

| 19 |

Following the Reverse Stock Split, the Board will
have the authority, subject to